DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FMNL1 | Formin-like 1 | Predicted membrane proteins
| | | | | Expressed in all |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HMGN1 | High mobility group nucleosome binding domain 1 | Predicted membrane proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
JTB | Jumping translocation breakpoint | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LITAF | Lipopolysaccharide-induced TNF factor | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LMAN1 | Lectin, mannose-binding, 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
MANEA | Mannosidase, endo-alpha | Enzymes Predicted membrane proteins
| | | | | Mixed |
MCAM | Melanoma cell adhesion molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MLANA | Melan-A | Predicted membrane proteins
| | | | | Tissue enriched |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCSTN | Nicastrin | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
NDUFA3 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
NDUFS4 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
NOL6 | Nucleolar protein 6 (RNA-associated) | Predicted membrane proteins
| | | | | Expressed in all |
NSDHL | NAD(P) dependent steroid dehydrogenase-like | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |